This forum thread continues to gain traction among AJP readers: “If the main manufacturers of low-dose Codeine don’t see a market and the generics come to the same conclusion, then what will happen to those for whom low-dose codeine was all they needed? Yes there is Paracetamol+Ibuprofen (P+I), (don’t have an ulcer/crook liver), but even for prescribers there will be no in between P+I and Panadeine Forte if the all low-dose Codeine options are gone.
“Also what person with temporary but acute pain that may have been happy with low-dose Codeine is going to be satisfied after spending the time & money to see a doctor to walk away with a low-dose instead of high dose Panadeine script? Another reason there will be no market for low-dose Codeine come 1 Feb 2018.”
- Who’s going to use MedsASSIST post Feb 1st?
- Meningococcal vaccine
- Medication review
- HMR claims
- Pharmacy employment in Queensland
Click here to visit the AJP Discussion Forum.
Haven’t registered yet? Click here.